BRN 5.56% 17.0¢ brainchip holdings ltd

Ann: Appendix 4D and 1H24 Financial Report, page-19

  1. 356 Posts.
    lightbulb Created with Sketch. 251
    I've been digging into BrainChip's financial reports for the first half of 2024 compared to 2023, and here's what I've noticed. Revenue dipped slightly by about 8%, which isn't great, but the big story is the significant reduction in losses. They've managed to slash their operating loss by 31% and their net loss by 33%, which brought the loss per share down from $0.93 to $0.60. That's a decent improvement.

    However, there's a downside too. The company's net tangible assets per share have taken a hit, dropping quite a bit, which suggests that the value of their tangible assets is declining. They did increase spending on R&D and sales/marketing, which could pay off later, but at least their general admin costs went down a bit.

    One of the most notable things is the massive reduction in share-based payment expenses, down by 80%. This likely means they issued fewer equity compensations this time around, which is probably a good move. Overall, while there are some positives in reducing their losses, they still have some challenges, particularly in maintaining revenue and asset values.

    After going through BrainChip's latest financial report, I noticed a few interesting developments beyond just the numbers. First off, they’ve signed a significant amendment to their agreement with LDA Capital. This is actually the third amendment to the Put Option Agreement (POA), which extends the deal for another year, with the possibility of extending it for two more years under the same terms if both parties agree. As part of this, BrainChip was required to draw down the remaining A$2.7 million by the end of 2024, along with an additional A$12 million.

    They also issued a couple of capital call notices this year—one in December 2023 and another in March 2024—leading to substantial cash inflows. These capital calls resulted in BrainChip raising millions in cash, which should provide some financial stability and support ongoing projects.

    So, while the financials are showing improvements in cutting losses, these agreements and capital injections could be crucial in helping them maintain momentum and fund their operations moving forward.

    It seems like they’re strategically positioning themselves for better days ahead — there’s a deal with Airbus mentioned. It looks like BrainChip has secured a partnership with Airbus to collaborate on developing advanced AI solutions using their Akida technology. This is a pretty big deal in my opinion because it could position BrainChip as a key player in the aerospace industry, which is increasingly relying on cutting-edge AI tech.

    This agreement could be a game-changer for BrainChip, opening up new opportunities in a high-tech, high-stakes industry. It feels like they’re really starting to carve out a niche for themselves with this kind of strategic partnership, and it could potentially drive some serious growth for the company moving forward.

    Definitely one to keep an eye on!
 
watchlist Created with Sketch. Add BRN (ASX) to my watchlist
(20min delay)
Last
17.0¢
Change
-0.010(5.56%)
Mkt cap ! $333.6M
Open High Low Value Volume
18.0¢ 18.5¢ 17.0¢ $2.303M 13.21M

Buyers (Bids)

No. Vol. Price($)
149 3707748 17.0¢
 

Sellers (Offers)

Price($) Vol. No.
17.5¢ 1173238 17
View Market Depth
Last trade - 16.10pm 27/08/2024 (20 minute delay) ?
BRN (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.